Schedule 13D ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Security class unavailable · CUSIP: 252828108

Event date: 2024-03-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.7200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-099432
Form type
SC 13D/A
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
Sep 12, 2024
Reporting period
Mar 21, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub